Beyond Hot Flashes: Investing in the Next Wave of Menopause Innovation
Scientists and clinicians are reimagining hormone replacement therapy and exploring ways to prolong ovarian function. By revisiting misconceptions and leveraging new delivery methods, menopause could become far more manageable—or even delayed. This is a prime opportunity for forward-thinking investors eager to shape the future of women’s healthcare.
Welcome to the latest issue of the Femmehealth Ventures Publication—your trusted source for insightful analysis of femtech innovations through an investor's lens, helping you identify the latest opportunities in women's health technology.
If this email was forwarded to you, you have awesome friends—click below to join. Don’t forget, you can always explore our archives to catch up on any past stories.
Today’s Brief:
💡Can Groundbreaking Treatments Delay Menopause and Redefine Hormone Therapy?
Scientists and clinicians are reimagining hormone replacement therapy and exploring ways to prolong ovarian function.
By revisiting misconceptions and leveraging new delivery methods (think transdermal patches or real-time hormone sensors), menopause could become far more manageable—or even delayed.
This is a prime opportunity for forward-thinking investors eager to shape the future of women’s healthcare.
Below is a concise breakdown of the most important insights from the latest research, especially tailored for you—our community of (aspiring) angel investors looking to understand where innovation meets opportunity.
📊 What Is Happening
Rising Demand for Specialists
Medical professionals certified in menopause care are in short supply. Despite a surge in interest—only 1,300 providers became certified in 2024 alone—waitlists for specialists often run months long.New-Age Hormone Therapy
A major reevaluation of the 2002 Women’s Health Initiative study has reignited the conversation around hormone replacement. Updated insights show that timing, dosage, and delivery methods (like patches) could be safer and more effective than once feared.Emerging Tech & Treatments
Non-Hormonal Drugs: Fezolinetant and elinzanetant target hot flushes but come with side effects.
Bioelectronic Devices: Wearable sensors and potential implantables could eventually regulate and dispense hormones on demand.
Ovary Preservation: Researchers are exploring ways to prolong ovarian function to mitigate the cascade of health risks that follow menopause.
Increased Funding & Advocacy
There’s a growing wave of advocacy and funding: the U.S. government’s White House Initiative pumped $113 million into women’s health research, ARPA-H is prioritising menopause innovation, and celebrity allies like Halle Berry are championing legislation to propel menopause research forward.
❓Why It Is Happening
Demand for Better Solutions
Half the population goes through menopause, often during prime career years. Conventional guidance—“just endure it”—is no longer acceptable. This unmet need is pushing both public and private sectors to seek more effective answers.Data-Driven Revisions
The original hormone-therapy scare was largely due to misinterpretations of study data. Subsequent reviews reveal potential benefits, especially if therapy starts early, with more precise dosing and new formulations.Societal Shifts & Open Dialogue
Stigma is fading as more people openly discuss menopausal symptoms. With increased awareness comes market opportunity, from telemedicine platforms to specialised medical practices.
❓Why It Will Keep Happening
Market Potential
The demographic is huge—every day in the United States, an estimated 6,000 women reach menopause, i.e., over two million each year (1)—and economic studies indicate that improving menopause care could significantly reduce healthcare costs related to osteoporosis, heart disease, and other post-menopausal conditions.Investment Momentum
High-profile funding rounds in women’s health startups (like Allara Health’s $26M Series B) signal strong investor confidence. Platforms addressing hormonal health are only growing.Ongoing Research & Collaboration
Global research hubs, plus government agencies like ARPA-H, continue to pump capital into menopause-focused science. Clinicians worldwide are getting specialised training, further fuelling innovation and service expansion.
📌 What You Can Do About It
If You’re an Investor
Look at specialised startups: telehealth platforms, wearable hormone trackers, and biotech companies developing novel therapies are ripe for early-stage investment.
Demand Data & Clinical Rigour: Funding rigorous clinical trials can help shape safer, better-informed hormone therapies.
If You’re a Healthcare Professional
Get Certified: Organisations like The Menopause Society offer competency exams and training to upskill medical providers.
Adopt Holistic Care: Acknowledge the multifaceted nature of menopause—lifestyle, mental health, and cardiovascular health—when developing treatment plans.
If You’re Experiencing Menopause
Seek Out Specialists: You deserve informed guidance. Look for menopause-certified providers or consider telemedicine alternatives if local resources are scarce.
Advocate for Yourself: Don’t settle for outdated advice; enquire about new delivery methods (e.g., patches), lower-dose regimens, or emerging treatments.
💰Bonus: How to Dive into the Menopause Market as an Aspiring Angel Investor
Identify White Spaces: Investigate underserved sub-niches, such as wearable devices that track hormones or AI-driven platforms that tailor treatments in real time.
Attend Menopause-Focused Conferences: Look for events hosted by The Menopause Society or the International Menopause Society to spot promising startups and research breakthroughs.
Partner with Established Investors: Collaborate with VCs or angel syndicates already active in the women’s health space. Shared expertise can de-risk your investment.
Support Education: Encourage your portfolio companies to invest in provider training and consumer outreach—well-informed clinicians and patients amplify demand and accelerate adoption.
We hope today’s breakdown offers insight into the investment potential within this emerging market. At Femmehealth Ventures, our mission is to keep you informed, empowered, and ready to seize opportunities that can transform women’s health. Ready to go deeper and get exclusive analysis? Upgrade to a paid subscription.
Stay informed and stay invested. Until next time…
References
(1) North American Menopause Society
A subscription gets you:
a chance to support my work ❤️
access to subscriber-only posts and archives
access to my health and fitness playbook
exclusive pre-release access to my upcoming book on investing in women’s health
Ways to Connect with Femmehealth Ventures
Sign-up for Femmehealth Ventures newsletter, which is published weekly on Sundays
Disclaimer
The content in this newsletter is for informational purposes only and does not constitute financial, investment, legal, or medical advice. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.
As a woman who is specialized in holistic and more ancient wisdom traditions for women, I have to speak up and say this really concerns me. Bleeding every month is actually very energy costly and I can’t imagine why any woman would want to have more years. For example, in traditional Chinese medicine, menopause is viewed as a way to extend a woman’s life because it is so energy costly. My desire would be to get through perimenopause, which can last up to 10 years and that’s been What my experience has been faster so I can get back to my life faster. I did find that as a holistic woman I wasn’t keen on hormone replacement therapy until this last year when I started to hear more such as Dr. Claire’s work however I’m releasing an article this week abouthow women’s bodies should be the cyclical world. We run the world by not the 24 male clock. Forcing the woman’s body into a 24 hour clock so she can be more productive than an economic structure like this is not gonna actually in my opinion from my studies benefit our health. Also, there’s so much research out there now that shows how important women pass their bleeding years are to society because they can give more energy instead of having to bleed every month. So again it just baffles me why any woman would want to extend her menses years. Maybe I’m missing something? Happy to hear more if I am absolutely.
This work is near and dear to my heart. I feel SO encouraged seeing the progress that’s being made in this space! I would love to hear more!